Literature DB >> 34345052

Have Current Systems of Pharmacovigilance Had Their Day?: THE "CON" SIDE.

Christine M Bond1.   

Abstract

Year:  2020        PMID： 34345052      PMCID： PMC8282190          DOI： 10.4212/cjhp.v73i2.2983

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  6 in total

1.  Reflections on attribution and decisions in pharmacovigilance.

Authors:  Ola Caster; I Ralph Edwards
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

2.  Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.

Authors:  David J McLernon; Christine M Bond; Philip C Hannaford; Margaret C Watson; Amanda J Lee; Lorna Hazell; Anthony Avery
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 3.  Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Authors:  A J Avery; C Anderson; C M Bond; H Fortnum; A Gifford; P C Hannaford; L Hazell; J Krska; A J Lee; D J McLernon; E Murphy; S Shakir; M C Watson
Journal:  Health Technol Assess       Date:  2011-05       Impact factor: 4.014

4.  CANADIAN THALIDOMIDE EXPERIENCE.

Authors:  J F WEBB
Journal:  Can Med Assoc J       Date:  1963-11-09       Impact factor: 8.262

Review 5.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

6.  An historical overview over Pharmacovigilance.

Authors:  Giulia Fornasier; Sara Francescon; Roberto Leone; Paolo Baldo
Journal:  Int J Clin Pharm       Date:  2018-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.